Key points are not available for this paper at this time.
Supplementary Figure S1. Examples of remarkable tumor regression in patients with KIT-only-mutant GIST during treatment with avapritinib 300 mg QD.
Heinrich et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: